News
ELF partner expertise in the spotlight
The European Lead Factory builds on an established partnership between public and private organisations, designed to promote innovation by ensuring in-depth collaboration and honest brokerage.
The partnership capitalises on the innovation of academia, the creativity and agility of small- and medium-sized enterprises (SMEs), and the experience and resources of large pharmaceutical companies.
Two of our SME partners were recently highlighted for the expertise they bring to the field of early drug discovery – showcasing the remarkable strength of the ELF network:
BioAscent, our partner responsible for the biophysical work carried out for public screens at the ELF, has seen growing demand for its Surface Plasmon Resonance expertise, a powerful technique used in the early drug discovery space to determine interactions between small molecules and novel drug targets. Read more
Symeres, longstanding ELF partner and co-owner of the Public Compound Collection, currently involved in resynthesis and hit confirmation efforts, has been recognised for “delivering world-class expertise in pharmaceutical R&D”, providing state-of-the-art lab services, and catering to a diverse customer base. Read more
We are proud to have established such a strong consortium of partners, and examples like this emphasize the valuable role that public-private partnerships like the ELF play in progressing drug discovery research.